fluphenazine sulfoxide结构式
|
常用名 | fluphenazine sulfoxide | 英文名 | fluphenazine sulfoxide |
---|---|---|---|---|
CAS号 | 1674-76-6 | 分子量 | 453.52100 | |
密度 | 1.43g/cm3 | 沸点 | 615.4ºC at 760mmHg | |
分子式 | C22H26F3N3O2S | 熔点 | 131-133ºC | |
MSDS | N/A | 闪点 | 326ºC |
英文名 | Fluphenazine Sulfoxide |
---|---|
英文别名 | 更多 |
密度 | 1.43g/cm3 |
---|---|
沸点 | 615.4ºC at 760mmHg |
熔点 | 131-133ºC |
分子式 | C22H26F3N3O2S |
分子量 | 453.52100 |
闪点 | 326ºC |
精确质量 | 453.17000 |
PSA | 66.23000 |
LogP | 4.13010 |
蒸汽压 | 5.28E-16mmHg at 25°C |
折射率 | 1.654 |
储存条件 | 2-8°C |
Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response.
Br. J. Psychiatry 158 , 658-65, (1991) The levels of fluphenazine and fluphenazine sulphoxide in schizophrenic patients who were randomly assigned to receive either 5 mg or 25 mg of fluphenazine decanoate every two weeks were monitored. Pa... |
|
Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
J. Psychiatry Neurosci. 19(4) , 254-64, (1994) This review covers some recent work on: 1. The effects of route of administration on the pharmacokinetics of fluphenazine and some of its metabolites; 2. The clinical pharmacokinetics of fluphenazine ... |
|
The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoate.
Psychopharmacology 93(3) , 369-73, (1987) Highly sensitive radioimmunoassays were applied to study the sulfoxidation of fluphenazine in 30 schizophrenic patients maintained on either 5 mg or 25 mg fluphenazine decanoate by intramuscular injec... |
Fluphenazine sulphoxide |
Fluphenazine sulfoxide |
2-[4-[3-[5-oxo-2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol |